Study blood changes in people with circulatory shock
Part of Heart & circulation, Infections clinical trials.
This study looks at how blood vessel and white blood cell aging changes during circulatory shock. Your participation may help doctors better understand what’s happening in the body during shock.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with circulatory shock
- You have health care insurance
- You must agree to take part in clinical research
- You cannot be pregnant
- You cannot be breastfeeding
- You cannot have a protective court order
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial aims to learn more about blood clots, inflammation, and blood vessel problems. It may help researchers better understand these conditions and how they affect people.
This study looks at people with a severe type of shock that affects both the heart and blood vessels, treated in the intensive care unit. It aims to understand how these patients recover and what factors impact their survival.
This trial studies specific body proteins to understand why fluid can leak from blood vessels during dangerous shock after infection or heart problems. If you (or your representative) qualify, your team will collect information and possibly samples to see whether these proteins relate to recovery and treatment response.
This trial looks at how the immune system changes after septic shock in adults in the ICU. It may help doctors better predict or manage complications by studying blood markers a few days after starting treatment.
This trial studies how blood flow and organ “perfusion” look in ICU patients who are struggling with infection and low blood pressure. It may help doctors better measure and manage shock by comparing hemodynamic readings during standard treatment.
This study tests a new way to check blood flow in the tiny blood vessels of the skin for people in the ICU with circulatory failure from sepsis or heart failure. It helps doctors understand how well blood is reaching tissues, which may guide treatment.
Hear when a new Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.